From: A review of valve surgery for rheumatic heart disease in Australia
 | All | RHD-related | Non-RHD | P value |
---|---|---|---|---|
N = 17227 | N = 1384 | N = 15843 | ||
Age (years) | 71.3 | 59.7 | 71.9 | <0.001 |
(Median (IQR)) | (61.2 – 78.3) | (50.9 – 71.4) | (62.3 – 78.6) | |
Sex (% female) | 37.3 | 64.5 | 35.0 | <0.001 |
(95% CI) | (36.6 – 38.1) | (61.9 – 67.0) | (34.2 – 35.7) | |
Indigenous status | 1.9 | 12.6 | 1.0 | <0.001 |
(% Aboriginal and Torres Strait Islander people) (95% CI) | (1.7 – 2.1) | (10.9 – 14.4) | (0.8 – 1.2) | |
Concomitant CABG | 39.1 | 21.2 | 40.7 | <0.001 |
(%, 95% CI) | (38.4 – 39.8) | (19.1 – 23.5) | (39.9 – 41.4) | |
Pre-operative comorbidities | Â | Â | Â | Â |
Diabetes | 23.2 | 20.3 | 23.4 | 0.009 |
(%, 95% CI) | (22.5 – 23.8) | (18.2 – 22.5) | (22.8 – 24.1) | |
Elevated Creatinine | 3.4 | 2.8 | 3.5 | 0.436 |
(% Cr > =200 μmol/L, 95% CI) | (3.1 – 3.7) | (2.0 – 03.8) | (3.2 – 03.8) | |
Chronic kidney disease | 36.7 | 31.2 | 37.2 | 0.814 |
(% eGFR < 60 mL/min/1.73 m2) (95% CI) | (36.0 – 37.5) | (28.8 – 33.7) | (36.5 – 38.0) | |
Hypertension | 67.0 | 53.0 | 68.2 | <0.001 |
(%, 95% CI) | (66.3 – 67.7) | (50.3 – 55.7) | (67.5 – 68.9) | |
Previous smoking | 53.1 | 52.7 | 53.1 | 0.955 |
(%, 95% CI) | (52.3 -53.8) | (50.0 - 55.3) | (52.3 - 53.9) | |
Current smoking | 16.0 | 25.1 | 15.2 | <0.001 |
(%, 95% CI) | (15.2 - 16.7) | (22.0 - 28.4) | (14.5 - 16.0) | |
Pre-operative status | Â | Â | Â | Â |
NYHA classes III & IV | 43.7 | 53.7 | 42.8 | 0.351 |
(%, 95% CI) | (42.9 – 44.4) | (51.0 – 56.4) | (42.0 – 43.6) | |
Atrial fibrillation | 19.3 | 40.5 | 17.4 | <0.001 |
(%, 95% CI) | (18.7 – 19.9) | (37.9 – 43.2) | (16.8 – 18.0) | |
LVEF >45% | 81.2 | 84.6 | 80.9 | 0.001 |
(%, 95% CI) | (80.6 – 81.8) | (82.6 – 86.5) | (80.3 – 81.5) | |
LVEF 45 – 60% | 12.1 | 10.9 | 12.2 | 0.154 |
(%, 95% CI) | (11.6 – 12.6) | (9.3 – 12.7) | (11.7 – 12.7) | |
LVEF <30% | 4.3 | 2.2 | 4.5 | <0.001 |
(%, 95% CI) | (4.0 – 4.6) | (1.5 – 3.2) | (4.2 – 4.8) | |
Previous procedures | Â | Â | Â | Â |
Valve surgery | 6.4 | 13.5 | 5.8 | <0.001 |
(%, 95% CI) | (6.1 – 6.8) | (11.8 – 15.4) | (5.4 – 6.2) | |
PBV | 4.9 | 20.7 | 3.3 | <0.001 |
(%, 95% CI) | (4.3 – 5.6) | (16.7 – 25.2) | (2.8 – 4.0) |